EPHA2 and cancer: We found double-positive samples in various cancers except for one stomach sample exhibiting pS-EphA2 positivity and pRSK negativity, suggesting a strong signalling correlation between EphA2 and RSK in human cancer tissues (Supplementary Fig. 8a–f).